These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 20547927)

  • 1. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.
    Abe K; Toba M; Alzoubi A; Ito M; Fagan KA; Cool CD; Voelkel NF; McMurtry IF; Oka M
    Circulation; 2010 Jun; 121(25):2747-54. PubMed ID: 20547927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.
    Cool CD; Stewart JS; Werahera P; Miller GJ; Williams RL; Voelkel NF; Tuder RM
    Am J Pathol; 1999 Aug; 155(2):411-9. PubMed ID: 10433934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
    Bogaard HJ; Legchenko E; Chaudhary KR; Sun XQ; Stewart DJ; Hansmann G
    Am J Respir Crit Care Med; 2019 Dec; 200(11):1447-1450. PubMed ID: 31437404
    [No Abstract]   [Full Text] [Related]  

  • 4. A cancer amidst us: the plexiform lesion in pulmonary arterial hypertension.
    Lee JY; Francis CM; Bauer NN; Gassman NR; Stevens T
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1142-L1144. PubMed ID: 32191119
    [No Abstract]   [Full Text] [Related]  

  • 5. The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up.
    Vitali SH; Hansmann G; Rose C; Fernandez-Gonzalez A; Scheid A; Mitsialis SA; Kourembanas S
    Pulm Circ; 2014 Dec; 4(4):619-29. PubMed ID: 25610598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel murine model of severe pulmonary arterial hypertension.
    Ciuclan L; Bonneau O; Hussey M; Duggan N; Holmes AM; Good R; Stringer R; Jones P; Morrell NW; Jarai G; Walker C; Westwick J; Thomas M
    Am J Respir Crit Care Med; 2011 Nov; 184(10):1171-82. PubMed ID: 21868504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated clinical classification of pulmonary hypertension.
    Simonneau G; Gatzoulis MA; Adatia I; Celermajer D; Denton C; Ghofrani A; Gomez Sanchez MA; Krishna Kumar R; Landzberg M; Machado RF; Olschewski H; Robbins IM; Souza R
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D34-41. PubMed ID: 24355639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension.
    Abe K; Shinoda M; Tanaka M; Kuwabara Y; Yoshida K; Hirooka Y; McMurtry IF; Oka M; Sunagawa K
    Cardiovasc Res; 2016 Jul; 111(1):16-25. PubMed ID: 27037259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.
    Toba M; Alzoubi A; O'Neill KD; Gairhe S; Matsumoto Y; Oshima K; Abe K; Oka M; McMurtry IF
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(2):H243-50. PubMed ID: 24240870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.
    Guignabert C; Tu L; Girerd B; Ricard N; Huertas A; Montani D; Humbert M
    Chest; 2015 Feb; 147(2):529-537. PubMed ID: 25644906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monocrotaline model of pulmonary hypertension in perspective.
    Gomez-Arroyo JG; Farkas L; Alhussaini AA; Farkas D; Kraskauskas D; Voelkel NF; Bogaard HJ
    Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(4):L363-9. PubMed ID: 21964406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension.
    Savai R; Al-Tamari HM; Sedding D; Kojonazarov B; Muecke C; Teske R; Capecchi MR; Weissmann N; Grimminger F; Seeger W; Schermuly RT; Pullamsetti SS
    Nat Med; 2014 Nov; 20(11):1289-300. PubMed ID: 25344740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.
    Aiello RJ; Bourassa PA; Zhang Q; Dubins J; Goldberg DR; De Lombaert S; Humbert M; Guignabert C; Cavasin MA; McKinsey TA; Paralkar V
    J Pharmacol Exp Ther; 2017 Feb; 360(2):267-279. PubMed ID: 27927914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
    Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
    Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension.
    Diebold I; Hennigs JK; Miyagawa K; Li CG; Nickel NP; Kaschwich M; Cao A; Wang L; Reddy S; Chen PI; Nakahira K; Alcazar MA; Hopper RK; Ji L; Feldman BJ; Rabinovitch M
    Cell Metab; 2015 Apr; 21(4):596-608. PubMed ID: 25863249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension.
    Al-Husseini A; Kraskauskas D; Mezzaroma E; Nordio A; Farkas D; Drake JI; Abbate A; Felty Q; Voelkel NF
    Pulm Circ; 2015 Mar; 5(1):101-16. PubMed ID: 25992275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats.
    Otsuki S; Sawada H; Yodoya N; Shinohara T; Kato T; Ohashi H; Zhang E; Imanaka-Yoshida K; Shimpo H; Maruyama K; Komada Y; Mitani Y
    PLoS One; 2015; 10(2):e0118655. PubMed ID: 25714834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension.
    Vaillancourt M; Ruffenach G; Meloche J; Bonnet S
    Can J Cardiol; 2015 Apr; 31(4):407-15. PubMed ID: 25630876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevant issues in the pathology and pathobiology of pulmonary hypertension.
    Tuder RM; Archer SL; Dorfmüller P; Erzurum SC; Guignabert C; Michelakis E; Rabinovitch M; Schermuly R; Stenmark KR; Morrell NW
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D4-12. PubMed ID: 24355640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.
    Voelkel NF; Gomez-Arroyo J
    Am J Respir Cell Mol Biol; 2014 Oct; 51(4):474-84. PubMed ID: 24932885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.